Mebucaïne Dolo, Lutschtablette

7680678800039 CH-67880 Lutschtablette
Mebucaïne Dolo, Lutschtablette
Mebucaïne Dolo, Lutschtablette
Mebucaïne Dolo, Lutschtablette
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Lutschtablette
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/01/2025
Patient information leaflet
Français
22/01/2025
Patient information leaflet
Italien
22/01/2025
Summary of Product Characteristics
Allemand
22/01/2025
Summary of Product Characteristics
Français
22/01/2025
Summary of Product Characteristics
Italien
22/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.75 MG Substance Wirkstoff (Principe actif)
(N/A)
2039.4 MG Substance HBESI
(N/A)
427.5 MG Substance HBESI
(N/A)
0.01 MG Substance HBESI
(N/A)
0.08 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
67880
Drug name
Mebucaïne Dolo, Lutschtablette
Galenic form
LUTT
ATC Code
R02AX01
Authorization status
Z
Dispensing category
D
First authorization
09/09/2021
Authorization expiration date
08/09/2026
IT Number
12.03.2.
Domain
Human medicine
Field of application
kurzzeitige symptomatische Behandlung schmerzhafter Entzündungen der Rachenschleimhaut

Package details

Description (FR)
MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce
Description (DE)
MEBUCAÏNE Dolo Lutschtabl 8.75 mg 16 Stk
Market launch
09/09/2021
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
24 TABL
GTIN: None
Not in V1